If you’re suffering from osteoarthritis or chronic knee pain, Genicular Artery Embolization (GAE) might be the solution you ...

Key Points Penumbra topped analyst forecasts with $339.5 million in GAAP revenue and $0.86 non-GAAP EPS, driven by double-digit U.S. thrombectomy growth. Gross margin (GAAP) expanded sharply to 66.0%, ...

In the preceding three months, 7 analysts have released ratings for Penumbra PEN, presenting a wide array of perspectives ...

Shares of medical device company Penumbra (NYSE:PEN) jumped 11.8% in the afternoon session after the company reported impressive second-quarter financial results that surpassed analyst expectations ...

Here’s why a wellness platform is announcing a clinical study on supporting fibroids with Chinese medicine to address a major gap in women’s health.

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second ...

The interventional radiology market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the ...